State-of-the-Art Mass Spectrometry Facility Advances Injury Biomarker Detection

Find out how scientists at the Mass Spectrometry Center, University of Maryland (A Waters Center of Innovation), are using state-of-the-art facilities for drug discovery and development worldwide. Hear how the methods developed in the laboratory using instruments including the Waters’ SYNAPT G2-S mass spectrometer and MSE technology are helping to identify injury-related biomarkers that can be used in the development of therapeutics.